Mehmood Khan, MD, is chief executive officer and board member of Life Biosciences Inc. In his role as CEO, Dr. Khan provides strategic direction and operational oversight across the organization. His vision of a more efficient and effective drug development pathway will drive innovation in the science and technology that Life Biosciences advances. Dr. Khan previously served as global vice chairman and chief scientific officer of PepsiCo. He played a pivotal role in the company’s global R&D efforts to create breakthrough innovations in food, beverages, and nutrition, including the incorporation of healthier and more nutritious offerings across its portfolio. Dr. Khan also oversaw their global sustainability initiatives. Prior to joining PepsiCo, Dr. Khan served as president of Global R&D at Takeda Pharmaceuticals, leading the global efforts of one of the largest pharmaceutical companies in the world by revenue. Before moving into industry, Dr. Khan had a distinguished medical career as a practicing faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as director of the Diabetes, Endocrine and Nutritional Trials Unit. Dr. Khan is a member of the board of directors of Reckitt Benckiser and Indigo Ag. He is also a member of the Visiting Committee on Advanced Technologies at the National Institute of Standards and Technology (NIST) and chair of the US Council on Competitiveness in Washington, DC. Dr. Khan earned his medical degree from the University of Liverpool Medical School, England and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis. He is a fellow of the Royal College of Physicians, London, a fellow of the American College of Endocrinology, and holds two ad honorem PhDs in humanities and international law. He has been exclusively featured in numerous publications including Fast Company's 100 Most Creative People in Business.